H. Lundbeck A/S (CPH: HLUN.B)
Denmark
· Delayed Price · Currency is DKK 43.06
-0.48 (-1.10%)
Nov 19, 2024, 1:39 PM CET
H. Lundbeck Revenue
H. Lundbeck had revenue of 5.72B DKK in the quarter ending September 30, 2024, with 15.55% growth. This brings the company's revenue in the last twelve months to 21.44B, up 9.31% year-over-year. In the year 2023, H. Lundbeck had annual revenue of 19.91B with 9.13% growth.
Revenue (ttm)
21.44B
Revenue Growth
+9.31%
P/S Ratio
2.08
Revenue / Employee
3.90M
Employees
5,681
Market Cap
42.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
| Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
| Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
| Dec 31, 2020 | 17.67B | 636.00M | 3.73% |
| Dec 31, 2019 | 17.04B | -1.08B | -5.97% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk A/S | 270.58B |
| Coloplast A/S | 27.03B |
| Genmab A/S | 19.84B |
| Demant A/S | 22.84B |
| Zealand Pharma A/S | 76.87M |
| H. Lundbeck A/S | 21.44B |
| ALK-Abelló A/S | 5.38B |
| Ambu A/S | 5.39B |